Evidence map›Paper›PMID 35501622›Full record

ArticleMolecular imaging and biology2022

Comparison of [

Caroline Stokke, Jakob Nordberg Nørgaard, Hilde Feiring Phillips, Alexander Sherwani, Syed Nuruddin, James Connelly, Fredrik Schjesvold, Mona-Elisabeth Revheim

Abstract readComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular imaging and biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Trial
  2. Review
  3. New Developments in Myeloma Treatment and Response Assessment.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2023
    Article
  4. Review
  5. Head-to-Head Comparison between FDG andDiagnostics (Basel, Switzerland) · 2023
    Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Caroline StokkeDivision for Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway. carsto@ous-hf.no.ORCID http://orcid.org/0000-0003-4465-9635
Jakob Nordberg NørgaardOslo Myeloma Center, Oslo University Hospital, Oslo, Norway.
Hilde Feiring PhillipsDivision for Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.
Alexander SherwaniDivision for Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.
Syed NuruddinNorwegian Medical Cyclotron Centre, Oslo, Norway.
James ConnellyDivision for Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.
Fredrik SchjesvoldOslo Myeloma Center, Oslo University Hospital, Oslo, Norway.
Mona-Elisabeth RevheimDivision for Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose[ PROCEDURES: Thirteen newly diagnosed transplant eligible MM patients were imaged both with [

resultsNine subjects were assessed positively by [

conclusionsBased on this pilot study, [

Indexed as

Fluorodeoxyglucose F18Multiple MyelomaCarboxylic AcidsCyclobutanesHumansPilot ProjectsPositron Emission Tomography Computed TomographyProspective StudiesRadiopharmaceuticalsCarboxylic AcidsCyclobutanesfluciclovine F-18Fluorodeoxyglucose F18Radiopharmaceuticals[18F]FACBC[18F]FDG[18F]fluciclovineAnti-1-amino-3-[18F]-fluorocyclobutane-1-carboxylic acidAxuminMultiple myelomaPET/CT

Identifiers

PMID35501622
PMCPMC9581841

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.